Lyme Disease Diagnostic Tests by EUROIMMUN
Manufacturer EUROIMMUN | Available Worldwide
EUROIMMU’s Lyme disease portfolio includes all tests for qualified two-tiered borreliosis diagnostics according to current recommendations. Antibody screening and confirmatory tests are based on optimised combinations of native and recombinant antigens, including early- and late-stage markers and exclusive antigens. Specialised CSF assays support diagnosis of neuroborreliosis. Scalable automation solutions are available for all analyses and throughput needs.
Lyme Disease Diagnostic Tests
- Broad range of Lyme disease screening (ELISA, ChLIA) and confirmatory (EUROLINE, EUROMicroblot, EUROLINE-WB) tests available
- Antigen portfolio includes VlsE from different Borrelia species, dimeric recombinant OspC advanced, p39 (BmpA), p83, p41, p58, p21, p20, p19, p18 and immunogenic lipids
- Parallel automated processing of ELISA and EUROMicroblot on the same instrument enables efficient high-throughput analyses
- Measurement of CXCL13 and intrathecal antibodies using CSF assays aids diagnosis of neuroborreliosis
Product Overview
Lyme Disease Diagnostic Tests
Manufacturer EUROIMMUN | Available Worldwide
Be the first to review this product
